Tilikum Therapeutics
PrivateLast Round
Seed
Jun 1, 2023
Company Overview
Tilikum Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in June 2023.
Tilikum Therapeutics is a biotechnology company developing a new class of small-molecule PARP1-selective inhibitors to treat treatment-resistant solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tilikum Therapeutics Comparables
Compare Tilikum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acerand Therapeutics | 87% | |
| Eikon Therapeutics | 76% | |
| IMPACT Therapeutics | 73% |
For institutional investors. Book with your work email.
Tilikum Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Tilikum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2023
Seed round led by Delin Ventures.
For institutional investors. Book with your work email.
Tilikum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tilikum Therapeutics's valuation, stock price, and market status.
Is Tilikum Therapeutics a public or private company?
Tilikum Therapeutics is a private company.
What is the current stock price of Tilikum Therapeutics?
Tilikum Therapeutics is a private company, so its shares have no public market price. Caplight tracks Tilikum Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tilikum Therapeutics worth (valuation)?
Valuation information for Tilikum Therapeutics is not publicly available.
Can I buy Tilikum Therapeutics stock?
Tilikum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tilikum Therapeutics's last funding round?
Tilikum Therapeutics's most recent funding round was Seed on June 1, 2023.
Who are the main investors in Tilikum Therapeutics?
Key investors in Tilikum Therapeutics include Delin Ventures.
Will Tilikum Therapeutics IPO soon?
No public IPO plans have been announced for Tilikum Therapeutics.
How can I track Tilikum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tilikum Therapeutics's shares on secondary markets.